Zobrazeno 1 - 10
of 62
pro vyhledávání: '"E. O. Rodionov"'
Autor:
O. V. Pankova, V. M. Perelmuter, D. S. Pismenny, A. A. Fedorov, D. M. Loos, E. O. Rodionov, M. V. Zavyalova, S. V. Miller
Publikováno v:
Сибирский онкологический журнал, Vol 23, Iss 2, Pp 64-71 (2024)
Background. Despite advances in surgical and therapy techniques, non-small cell lung cancer (NSCLC) is one of the most common cancers and the leading cause of cancer-related death. Therefore, it is increasingly important to search for markers that pr
Externí odkaz:
https://doaj.org/article/df9e214661e3455c917bbe0b63003e24
Autor:
D. E. Kulbakin, E. L. Choynzonov, I. K. Fedorova, E. V. Obkhodskaya, A. V. Obkhodskiy, E. O. Rodionov, V. I. Sachkov, V. I. Chernov
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 6, Pp 7-15 (2024)
The purpose of the study was to evaluate diagnostic capabilities of the gas analysis sensor device used for the study of exhaled gas samples obtained from patients with oropharyngeal and laryngeal cancers.Material and Methods. Exhaled gas samples fro
Externí odkaz:
https://doaj.org/article/b05212d361a0445e95628ab5e9f536b3
Autor:
E. O. Rodionov, S. V. Miller, M. M. Tsyganov, L. D. Zhuikova, L. V. Pikalova, O. V. Pankova, V. M. Perelmuter, D. V. Podolko, A. A. Mokh, O. A. Ananina, D. S. Pismenny, V. A. Markovich, D. M. Loos, N. V. Litvyakov
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 6, Pp 45-54 (2024)
Surgery is the standard of care for non-small cell lung cancer (NSCLC). The overall survival rates especially in patients with locally advanced lung cancer are low. The resistance of cancer cells to chemotherapeutic drugs reduces the efficacy of trea
Externí odkaz:
https://doaj.org/article/f266df22513749ba930fcba9fc78fb24
Autor:
A. A. Fedorov, N. A. Ermak, E. B. Topolnitskiy, N. A. Shefer, E. O. Rodionov, O. V. Pankova, N. V. Cherdyntseva, M. N. Stakheyeva
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 4, Pp 55-64 (2023)
The mechanism of the relationship between pretumor changes in the bronchial respiratory epithelium and the risk of progression of non-small cell lung cancer (NSCLC) remains unclear. It has been suggested that the relationship between reactive changes
Externí odkaz:
https://doaj.org/article/360bd55ff8ed4aec921ab4d69c873375
Autor:
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. O. Popova, M. M. Tsyganov, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova, N. V. Litviakov
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 24-34 (2023)
Peritoneal carcinomatosis is associated with poor prognosis in gastric cancer patients. Stage IV gastric cancer (GC) is diagnosed in 39.8 % of patients; local metastases without evidence of distant metastases occur only in 18–20 % of stage IV gastr
Externí odkaz:
https://doaj.org/article/375ce25ce9ed4f46894b171b5b33e323
Autor:
O. V. Pankova, L. A. Tashireva, E. O. Rodionov, S. V. Мiller, T. S. Gerashchenko, D. S. Pismenny, M. E. Zavyalova, E. V. Denisov, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 25-37 (2023)
Background. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains
Externí odkaz:
https://doaj.org/article/f06aab916cf44c66917dc40cc909644e
Autor:
M. V. Zavyalova, D. M. Loos, D. S. Pismenny, A. A. Durova, E. S. Andryukhova, E. O. Rodionov, S. V. Miller, S. A. Tuzikov, O. V. Pankova, L. A. Tashireva, S. V. Vtorushin, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 69-81 (2022)
The aim of the study: to examine the relationship between the morphological diversity of non-small cell lung cancer and the frequency of lymph node metastasis in groups of patients with different epithelial conditions in the bronchi adjacent to the t
Externí odkaz:
https://doaj.org/article/ba516f1d1385401a8d8b0b48f2eec6a4
Autor:
M. M. Tsyganov, M. K. Ibragimova, E. O. Rodionov, A. A. Frolova, S. V. Miller, O. V. Cheremisina, S. A. Tuzikov, N. V. Litvyakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 253-260 (2022)
Introduction. To date, one of the reasons for the ineffectiveness of chemotherapy in various malignant neoplasms, including lung cancer, is the formation of the multidrug resistance (MDR) phenotype in tumor cells, which is caused by the expression of
Externí odkaz:
https://doaj.org/article/73391dd88ebb4b658f110b95736eddc9
Autor:
S. Yu. Dobner, S. V. Fedosenko, E. O. Rodionov, N. D. Yarovoy, V. A. Petrov, S. A. Tuzikov, E. A. Starovoitova, I. A. Samykina
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 3, Pp 41-49 (2022)
Background. A combination of different types of lung cancer and chronic obstructive pulmonary disease (COPD) is very common. COPD, accompanied by ventilation disorders and, often, respiratory failure, is a significant additional risk factor for morta
Externí odkaz:
https://doaj.org/article/1f3a332189644842ab1064efd4bdd895
Autor:
A. A. Fedorov, N. A. Ermak, T. S. Gerashchenko, E. B. Topolnitskii, N. A. Shefer, E. O. Rodionov, M. N. Stakheyeva
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 4, Pp 124-136 (2022)
Macrophages are key components of the innate immune system. The variability of the macrophage’s participation in tumor progression, determined by their functional polarization, opens up a wide prospect for modulating their functional profile, prima
Externí odkaz:
https://doaj.org/article/aabb10f8dd2448dc8ed9c4eeb9024835